May 15, 2018
Interfering with the motion of a kinase enzyme might be a new approach for the development of anti-cancer drugs, new UA-led research suggests. Revealing all the steps required to activate an enzyme called a protein kinase may identify new ways to target cancer, according to new University of Arizona-led research. […]
